ACLX Q2 2024 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+91.5% YoY

Gross Profit

$26M95.5% margin

Operating Income

-$35M-127.8% margin

Net Income

-$27M-99.3% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

-30.2%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$39M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$734M

Total Liabilities

$247M

Stockholders' Equity

$487M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$14M	+91.5%
Gross Profit	$26M	$14M	+92.2%
Operating Income	-$35M	-$30M	-18.4%
Net Income	-$27M	-$24M	-14.0%